| By Business Wire |
Article Rating: |
|
| March 7, 2013 07:30 AM EST |
|
|
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to
transforming medicine that transforms lives, announced today that John
R. Plachetka, Pharm.D., the Company’s Chairman, President and Chief
Executive Officer, will present at the 25th Annual ROTH
Conference on Tuesday, March 19, 2013 at 9:00 a.m. (PT), at the
Ritz-Carlton Hotel in Laguna Niguel, California. The presentation will
be webcast and available for replay on POZEN’s home page at www.pozen.com.
About POZEN
POZEN Inc. is a small pharmaceutical company that specializes in
developing novel therapeutics for unmet medical needs and licensing
those products to larger pharmaceutical companies for commercialization.
By utilizing a unique in-source model and focusing on integrated
therapies, POZEN has successfully developed and obtained FDA approval of
two self-invented products in two years. Funded by these
milestone/royalty streams, POZEN is now creating a portfolio of
cost-effective, evidence based integrated aspirin therapies designed to
enable the full power of aspirin by reducing its GI damage.
POZEN is currently seeking strategic partners to help maximize the
opportunity for its portfolio assets.
The Company's common stock is traded under the symbol “POZN” on The
NASDAQ Global Market. For more detailed company information, including
copies of this and other press releases, please visit www.pozen.com.
